“…Other spontaneous reporting systems have also produced valuable information particularly from Sweden where reporting of suspected adverse effects is compulsory and Finland which has an excellent record-linkage system with other bodies of data. Examples from the Swedish agency include details of drug-related deaths (Bottiger, Norlander, Strandberg & Westerholm, 1974), leucopenia (Westerholm & Reizenstein, 1970) and thrombocytopenia (Bottiger & Westerholm, 1973), and from the Finnish agency include the impressive speed with which agranulocytosis was recognized after use of the drug clozapine and the drug removed from the market (Anderman & Griffiths, 1977; Idanpaan-Heikkila, Alhava, Olkinuora . Using the data from such agencies it is possible for certain rare events to obtain an estimate of the incidence of the condition in the community (Idanpaan-Heikkila Inman, 1977b).…”